Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03328182 · ClinicalTrials.gov registry record · NA

Assessment of an Oral Endotracheal Subglottic Tube Holder

A NA study of Intubation, sponsored by Hollister Incorporated.

Completed
Registry status
NA
Development phase
34
Enrollment target
4
Study locations

NCT03328182: Completed NA study of Intubation, sponsored by Hollister Incorporated.

NCT03328182 is a NA study of Intubation that has completed, run by Hollister Incorporated. The registered enrollment target is 34 participants, below the 2,873-participant average among 4 other Intubation trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03328182, a NA study of Intubation, has completed, sponsored by Hollister Incorporated.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
4
Study locations

Study Summary

This study is designed to assess the acceptability and usability of a new Endotracheal Tube (ET) holding device for an orally intubated patient.

Primary Outcome

The overall acceptability relating to general experience with the study product during use will be rated with a 5-point Likert scale ranging from 1=Very Unacceptable to 5=Very Acceptable

Conditions Studied

Interventions

  • DEVICE New oral endotracheal tube holder

Study Locations (4)

Oregon

  • Legacy Mount Hood Medical Center - Gresham
  • Legacy Good Samaritan Medical Center - Portland
  • Legacy Emanuel Hospital & Health Center - Portland

California

  • Community Regional Medical Center - Fresno

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2017-10-23
Est. Completion 2018-06-15
Phase NA
Hollister Incorporated

11 total trials

What the finished NCT03328182 record still lists

NCT03328182 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 2,873-participant average among 4 other Intubation trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Intubation appearing as the primary indexed condition, and to 1 intervention - of which New oral endotracheal tube holder is the first listed.

NCT03328182 reports a single indexed study location in Oregon, California.

Frequently Asked Questions

What is clinical trial NCT03328182 about?

NCT03328182 is a clinical study titled "Assessment of an Oral Endotracheal Subglottic Tube Holder". This study is designed to assess the acceptability and usability of a new Endotracheal Tube (ET) holding device for an orally intubated patient.

What is the current status of trial NCT03328182?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2017-10-23. Estimated completion is 2018-06-15.

What conditions does trial NCT03328182 study?

This clinical trial studies the following conditions: Intubation.

What interventions are being tested in trial NCT03328182?

The interventions under investigation include: New oral endotracheal tube holder (DEVICE).

Who is sponsoring clinical trial NCT03328182?

This trial is sponsored by Hollister Incorporated, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03328182 being conducted?

This trial has 4 study locations across California, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intubation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03328182, the US trial registry maintained by the National Library of Medicine. NCT03328182 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.